Figure 2From: Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeExpected cumulative incidence over 25 years in a screened group of ages 50 to 54 and in an unscreened group of age 55 to 59 at recruitment at the start of follow-up.Back to article page